Cabaletta Bio (CABA) Cash from Investing Activities (2019 - 2025)

Cabaletta Bio's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $49.8 million for Q4 2025.

• In Q4 2025, Cash from Investing Activities rose 310.71% year-over-year to $49.8 million; the TTM figure through Dec 2025 stood at -$50.3 million (down 206.3% YoY), while the FY2025 annual figure was -$50.3 million, down 206.3% from the prior year.
• Cash from Investing Activities for Q4 2025 stood at $49.8 million, up from -$50.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $49.8 million in Q4 2025, with the low at -$50.1 million in Q3 2025.
• The 5-year median for Cash from Investing Activities is $938000.0 (2021), against an average of -$2.3 million.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities plunged 5261.02% in 2023, then soared 18941.54% in 2024.
• Cabaletta Bio's Cash from Investing Activities stood at $849000.0 in 2021, then tumbled by 137.22% to -$316000.0 in 2022, then jumped by 459.49% to $1.1 million in 2023, then jumped by 967.25% to $12.1 million in 2024, then soared by 310.71% to $49.8 million in 2025.
• Business Quant data shows CABA's Cash from Investing Activities at $49.8 million in Q4 2025, -$50.1 million in Q3 2025, and -$49.2 million in Q2 2025.